美丽田园股东结构优化落定 董事会焕新

Core Viewpoint - The exit of CPE as a major shareholder of Meili Tianyuan Medical Health Industry Co., Ltd. is expected to enhance the company's shareholder structure and market confidence, while introducing new long-term investors to support its strategic development [1][2]. Group 1: Shareholder Structure Changes - CPE has successfully completed the sale of 51.32 million shares, ceasing to be a major shareholder as of August 18 [1]. - The exit of CPE is anticipated to stabilize the shareholder structure and improve market liquidity by increasing the proportion of circulating shares [1]. - New significant shareholders, Defo Capital and Nairui Health Technology Co., Ltd., hold 9.71% and 7.21% of shares respectively, enhancing the company's governance [1][2]. Group 2: Strategic Implications of New Shareholders - Defo Capital brings long-term stable capital and industry expertise, supporting future mergers and strategic planning [2]. - Nairui's investment creates a synergistic model between industry and capital, complementing Meili Tianyuan's existing business and facilitating market expansion in the Greater Bay Area [2]. Group 3: Capital Market Value Enhancement Plan - The shareholder structure adjustment is a key part of the company's capital market value enhancement plan, which includes establishing a long-term shareholder return mechanism and optimizing capital structure [3]. - The company commits to distributing at least 50% of annual net profit to dividends over the next three fiscal years, barring special circumstances [3]. - The plan also involves continuous introduction of long-term strategic investors to build a healthier and more diverse shareholder ecosystem [3].